Search Results - harvey+pass

2 Results Sort By:
Biomarkers for Diagnosis of Lung Cancer
In 2021, 134,592 people died from lung cancer, or 22% of all cancer deaths. Lung cancer is the leading cause of cancer death overall and among both men and women. While the increased use of CT screening for lung cancer has resulted in a reduction in lung cancer mortality, it has also resulted in an increased detection of benign pulmonary nodules. Patients...
Published: 10/29/2024   |   Inventor(s): Joshua LaBaer, Ji Qiu, Jie Wang, Garrick Wallstrom, Jin Park, William Rom, Harvey Pass
Keywords(s): Autoantibody, Biomarker discovery
Category(s): Bioanalytical Assays, Chemistries & Devices, Diagnostic Assays/Devices, Life Science (All LS Techs), Medical Diagnostics/Sensors, Proteomic Assays/Reagents/Tools
Mesothelioma Biomarker - High Mobility Group Box 1 (HMGB1) protein as a novel, sensitive biomarker for detecting asbestos exposure and mesothelioma
Malignant mesothelioma, associated with asbestos or erionite exposure, is an aggressive and lethal cancer of the mesothelium, the protective lining that covers many internal organs, and is most commonly found in the pleura (outer lining of the lungs). The inventors discovered that misregulation of a protein called High Mobility Group Box 1 (HMGB1) is...
Published: 2/29/2024   |   Inventor(s): Haining Yang, Michele Carbone, Harvey Pass
Keywords(s): Diagnostic:Marker, Healthcare:Diagnostic Tool, Healthcare:Oncology, Screening:Detection
Category(s): Healthcare, Diagnostic, Diagnostic, Therapeutic